INSIGHTS ON DRUG DEVELOPMENT
-
Accelerating Phase: Supply Without Sacrificing Discipline
Faster clinical supply delivery starts with the right strategy. Explore how planning, collaboration, communication, and quality systems keep programs on track.
-
Deciphering Nanoparticle Properties With AF4
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Get More From Less: AMP Chemistry Outperforms Hybrid Capture
Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.
-
If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?
Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?
-
AI Enabled Pharmaceutical Cocrystal Screening9/3/2026
Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.
-
Alzheimer's Disease Pathway3/24/2025
Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.
-
How To Benchmark Your Digital Transformation Performance And AI-Readiness6/18/2026
AI investment is rising across life sciences, but data challenges stall real-world adoption. Discover what is holding teams back and how to turn AI potential into practical scientific impact.
-
Assessing Viability And Real-Time Apoptosis/Necrosis3/17/2025
Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
Easy Automation For Cell-Based Assays10/10/2025
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
DRUG DEVELOPMENT SOLUTIONS
-
Overcome protein expression bottlenecks with a scalable insect-based platform that delivers faster development, predictable scale-up, and consistent manufacturing.
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.